Nowa wersja platformy, zawierająca wyłącznie zasoby pełnotekstowe, jest już dostępna.
Przejdź na


Preferencje help
Widoczny [Schowaj] Abstrakt
Liczba wyników
2014 | 9 | 4 | 565-573
Tytuł artykułu

Antibiotics in severe acute pancreatitis

Treść / Zawartość
Warianty tytułu
Języki publikacji
Acute pancreatitis (AP) is a local inflammatory response with systemic effects and an adverse evolution in 20% of cases. Its mortality rate is 5–10% in sterile and 15–40% in infected pancreatic necrosis. Infection is widely accepted as the main reason of death in AP. The evidence to enable a recommendation about antibiotic prophylaxis against infection of pancreatic necrosis is conflicting and difficult to interpret. Up to date, there is no evidence that supports the routine use of antibiotic prophylaxis in patients with severe AP. Treatment on demand seems to be the better option, avoiding excessive treatment and selection of bacterial. In infected acute pancreatitis, antibiotics of choice are imipenem, meronem or tigecycline in patients allergic to beta-lactams. Also fluconazole must be given in determinate clinical situations.

Opis fizyczny
  • General Surgery Service, Punta Europa Hospital, Algeciras, Spain
  • HPB Surgical Unit, Miguel Servet University Hospital, Zaragoza, Spain
  • [1] Dervenis C, Johnson CD, Bassi C, et al. Diagnosis, objective assessment of severity, and management of acute pancreatitis. Santorini consensus conference. Int J Pancreatol 1999; 25: 195–210
  • [2] Beger H. G., Rau B., Isenmann R. et al. Antibiotic Prophylaxis in Severe Acute Pancreatitis. Pancreatology 2005; 5: 10–19[Crossref]
  • [3] Bradley EL 3rd. A clinically based classification system for acute pancreatitis. Summary of the International Symposium on Acute Pancreatitis, Atlanta, Ga, September 11 through 13, 1992. Arch Surg, 1993; 128: 586–590
  • [4] Bassi C. Infected pancreatic necrosis. Int J Pancreatol, 1994; 16:1–10
  • [5] Buchler MW, Gloor B, Muller CA, Friess H, Seller ChA, Uhl W. Acute necrotizing pancreatitis: treatment strategy according to the status of infection. Ann Surg, 2000; 232: 619–26[Crossref]
  • [6] Bradley E, Allen K. A prospective longitudinal study of observation versus surgical intervention in the management of necrotizing pancreatitis. Am J Surg 1991; 161: 19–25[Crossref]
  • [7] Widdison A, Karanjia N. Pancreatic infection complicating acute pancreatitis. Br J Surg 1993; 80: 148–154[Crossref]
  • [8] Büchler P, Reber H. Surgical approach in patients with acute pancreatitis. Is infected or sterile necrosis an indication-in whom should this be done, when and why? Gastroenterology Clinics of North America 1999; 28: 661–671[Crossref]
  • [9] Wyncoll D. The management of severe acute pancreatitis: an evidence-based review of the literature. Inpenetracióntensive Care Med 1999; 25: 146–156[Crossref]
  • [10] Fritz S, Hackert T, Hartwig W, et al. Bacterial translocation and infected pancreatic necrosis in acute necrotizing pancreatitis derives from small bowel rather than from colon Am J Surg 2010; 200(1): 111–117[Crossref]
  • [11] Lowham A, Lavelle J, Leese T. Mortality from acute pancreatitis. Late septic deaths can be avoided but some early deaths still occur. Int J Pancreatol 1999; 25: 103–106[Crossref]
  • [12] Tenner S, Sica G, Bank P, et al. Relationship of necrosis to organ failure in severe acute pancreatitis. Gastroenterology 1997; 113: 899–903[Crossref]
  • [13] Luiten E, Hop W, Lange J, et al. Differential prognosis of gram negative versus gram positive infected and sterile pancreatic necrosis: result of a randomized trial in patients with severe acute pancreatitis treated with adjuvant selective decontamination. Clin Infect Dis 1997; 25: 811–6[Crossref]
  • [14] Delcenserie R, Yzet T, Ducroix J. Prophylactic antibiotics in treatment of severe acute alcoholic pancreatitis. Pancreas 1996; 13: 198–201
  • [15] Mann D, Hershman M, Hittinger R et al. Multicentre audit of death from acute pancreatitis. Br J Surg 1994; 81: 890–893[Crossref]
  • [16] Galvez S. Profilaxis antibiótica en la pancreatitis aguda grave. Clínicas de Medicina Intensiva. Fideco 1999; 339–349
  • [17] Nordback I, Sand J, Saaristo R, et al. Early treatment with antibiotics reduces the need for surgery in acute necrotizing pancreatitis - a single-center randomized study. J Gastrointest Surg 2001; 5: 113–118[Crossref]
  • [18] Pederzoli P, Bassi C, Vesentini S, et al. A randomized multicenter clinical trial of antibiotic prophylaxis of septic complications in acute necrotizing pancreatitis with imipenem. Surg Gynecol Obstet 1993; 176:480–483
  • [19] Isenmann R, Runzi M, Kron M, et al. Prophylactic antibiotic treatment in patients with predicted severe acute pancreatitis: a placebo-controlled, doubleblind trial. Gastroenterology 2004; 126:997–1004[Crossref]
  • [20] Sainio V, Kemppainen E, Puolakkainen P, et al. Early antibiotic treatment in acute necrotising pancreatitis. Lancet 1995; 346:663–667[Crossref]
  • [21] Schwarz M, Isenmann R, Meyer H, et al. Antibiotic use in necrotizing pancreatitis. Results of a controlled study. Dtsch Med Wochenschr 1997; 122:356–361[Crossref]
  • [22] Bassi C, Larvin M, Villatoro E. Antibiotic therapy for prophylaxis against infection of pancreatic necrosis in acute pancreatitis (Cochrane Methodology Review). Chichester: UK, John Wiley & Sons Ltd, The Cochrane Library, issue 4, 2003
  • [23] Howes R, Zuidema G, Cameron J. Evaluation of prophylactic antibiotics in acute pancreatitis. J Surg Res 1975; 18: 197–200[Crossref]
  • [24] Craig RM, Dordal E, Myles L. The use of ampicillin in acute pancreatitis. Ann Intern Med 1975; 83:831–832[Crossref]
  • [25] Finch W, Sawyers J, Schenker S. A prospective study to determine the efficacy of antibiotics in acute pancreatitis. Ann Surg 1976; 183: 667–671[Crossref]
  • [26] Bassi C, Falconi M, Talamini G, et al. Controlled clinical trial of pefloxacine versus imipenem in severe acute pancreatitis. Gastroenterology. 1998; 115: 1513–1517[Crossref]
  • [27] Luiten EJ, Hop WC, Lange JF, et al. Controlled clinical trial of selective decontamination for the treatment of severe acute pancreatitis. Ann Surg 1995; 222:57–65[Crossref]
  • [28] Golub R, Siddigi F, Pohl D. Role of antibiotics in acute pancreatitis: A meta-analysis. Gastrointest Surg 1998; 2: 496–503[Crossref]
  • [29] Johnson C. Antibiotic prophylaxis in severe acute pancreatitis. Br J Surg 1996; 83: 883–884[Crossref]
  • [30] Moody F, Haley-Russell D, Muncy D. Intestinal transit and bacterial translocation in obstructive pancreatitis. Dig Dis Sci 1995; 40: 1798–1804[Crossref]
  • [31] Powell J, Miles R, Siriwardena A. Review: Antibiotic prophylaxis in the initial management of severe acute pancreatitis. Br J Surg 1998; 85: 582–587[Crossref]
  • [32] Büchler M, Malfertheiner P, Frieβ H, et al. Human pancreatic tissue concentration of bactericidal antibiotics. Gastroenterology 1992; 103: 1902–1908
  • [33] Kochhar R, Ahammed SK, Chakrabarti A, Ray P, Sinha SK, Dutta U, Wig JD, Singh K. Prevalence and outcome of fungal infection in patients with severe acute pancreatitis. J Gastroenterol Hepatol. 2009 May; 24(5): 743–747[Crossref]
  • [34] De Waele JJ, Vogelaers D, Blot S, Colardyn F. Fungal infections in patients with severe acute pancreatitis and the use of prophylactic therapy. Clin Infect Dis. 2003 Jul 15; 37(2): 208–213[Crossref]
  • [35] Dellinger RP, Carlet JM, Masur H, et al. Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock. Crit Care Med 2004; 32:858–873[Crossref]
  • [36] Kochhar R, Noor MT, Wig J. Fungal infections in severe acute pancreatitis. J Gastroenterol Hepatol. 2011 Jun; 26(6): 952–959[Crossref]
  • [37] Dellinger EP, Tellado JM, Soto NE, Ashley SW, Barie PS, Dugernier T, Imrie CW, Johnson CD, Knaebel HP, Laterre PF, et al. Early antibiotic treatment for severe acute necrotizing pancreatitis: a randomized, double-blind, placebo-controlled study. Ann Surg. 2007; 245:674–683[Crossref]
  • [38] Brattstrôm C, Malmborg AS, Tyden G. Penetration of imipenem into human pancreatic juice following single intravenous dose administration. Chemotherapy. 1989; 35: 83–87[Crossref]
  • [39] Buchler M, Malfertheiner P, Friess H, et al. Human pancreatic tissue concentration of bactericidal antibiotics. Gastroenterology. 1992; 103(6): 1902–1908
  • [40] Minelli EB, Benini A, Bassi C, Abbas H, Falconi M, Locatelli F, de Marco R, Pederzoli P. Antimicrobial activity of human pancreatic juice and its interaction with antibiotics. Antimicrob Agents Chemother. 1996 Sep; 40(9): 2099–2105 [PubMed]
  • [41] Wittau M, Wagner E, Kaever V, Koal T, Henne-Bruns D, Isenmann R. Intraabdominal tissue concentration of ertapenem. J Antimicrob Chemother. 2006 Feb; 57(2): 312–316[Crossref]
  • [42] Brattström C, Malborg AS, Tydén G. Penetration of ciprofloxacin and ofloxacin into pancreatic juice. Chemioterapia. 1987; 6: 295–297
  • [43] Pederzoli, P., M. Falconi, C. Bassi, S. Vesentini, F. Orcalli, F. Scaglione, A. Messori, and N. Martini. Ciprofloxacin penetration in pancreatic juice. Chemotherapy. 1987; 33: 397–401[Crossref]
  • [44] Isenmann R, Friess H, Schlegel P, Fleischer K, Buchler MW. Penetration of ciprofloxacin into the human pancreas. Infection. 1994; 22: 343–346[Crossref]
  • [45] Adam U, Herms S, Werner U, Strubelt H, Makowiec F, Hopt UT, et al. The penetration of ciprofloxacin into human pancreatic and peri pancreatic necrosis in acute necrotizing pancreatitis. Infection. 2001; 29:326–331[Crossref]
  • [46] Malmborg AS, Brattström C, Tydén G. Penetration of pefloxacin into human allograft pancreatic juice. J Antimicrob Chemother. 1990; 25:393–397[Crossref]
  • [47] Bertazzoni ME, Benini A, Muner A, Bassi C, Abbas H, Pederzoli P. Pefloxacin penetration into human necrotic pancreatic tissue. J Antimicrob Chemother. 1996; 38: 237–243[Crossref]
  • [48] Wacke R, Forster S, Adam U, Mundkowski RG, Klar E, Hopt UT, et al. Penetration of moxifloxacin into the human pancreas following a single intravenous or oral dose. J Antimicrob Chemother. 2006; 58: 994–999[Crossref]
  • [49] Wallace JR, Cushing RD, Bawdon RE, Sugawa C, Lucas CE, Ledgerwood AM. Assessment of antimicrobial penetrance into the pancreatic juice in humans. Surg Gynecol Obstet. 1986; 162: 313–316
  • [50] Buchler M, Malfertheiner P, Friess H, Bittner R, Vanek E, Schlegel P et al. The penetration of antibiotics into human pancreas. Infection. 1989; 17:20–25[Crossref]
  • [51] Brattström C, Malmborg AS, Tydén G. Penetration of clindamycin, cefoxitin, and piperacillin into pancreatic juice in man. Surgery. 1988 May; 103(5): 563–567
  • [52] Martin C, Cottin A, Francois-Godfroy N, Mallet MN, Martin A, Sastre B, et al. Concentrations of prophylactic ceftriaxone in abdominal tissues during pancreatic surgery. J Antimicrob Chemother. 1997; 40: 445–448[Crossref]
  • [53] Drewelow B, Koch K, Otto C, Franke A, Riethling AK. Penetration of ceftazidime into human pancreas. Infection. 1993; 21:229–234[Crossref]
  • [54] Delcenserie R, Dellion-Lozinguez MP, Yzet T, Lepointe B, Hary L, Badoui R et al. Pancreatic concentrations of cefepime. J Antimicrob Chemother. 2001; 47: 711–713[Crossref]
  • [55] Wallace JR, Johnson J, Lucas CE, Cushing R, Ledgerwood AM, Sugawa C. Assessment of pancreatic ductal penetration of antibiotics. Am Surg. 1984; 50(12): 666–667
  • [56] Shrikhande S, Friess H, Issenegger C, Martignoni ME, Yong H, Gloor B, Yeates R, Kleeff J, Büchler MW. Fluconazole penetration into the pancreas. Antimicrob Agents Chemother. 2000 September; 44(9): 2569–2571[Crossref]
  • [57] Villatoro E, Mulla M, Larvin M. Antibiotic therapy for prophylaxis against infection of pancreatic necrosis in acute pancreatitis. Cochrane Database of Systematic Reviews 2010, Issue 5. Art. No: CD002941. DOI: 10.1002/14651858.CD002941. pub 3 [Crossref]
  • [58] Heinrich S, Schäfer M, Rousson V, Clavien PA. Evidence-based treatment of acute pancreatitis: a look at established paradigms. Ann Surg. 2006 Feb; 243(2): 154–168[Crossref]
  • [59] Mazaki T, Ishii Y, Takayama T. Meta-analysis of prophylactic antibiotic use in acute necrotizing pancreatitis. Br J Surg. 2006 Jun; 93(6): 674–684[Crossref]
  • [60] Xiong GS, Wu SM, Wang ZH. Role of prophylactic antibiotic administration in severe acute pancreatitis: a meta-analysis. Med Princ Pract. 2006; 15(2): 106–110[Crossref]
  • [61] Hart PA, Bechtold ML, Marshall JB, Choudhary A, Puli SR, Roy PK. Prophylactic antibiotics in necrotizing pancreatitis: a meta-analysis. South Med J. 2008 Nov; 101(11): 1126–1131[Crossref]
  • [62] Bai Y, Gao J, Zou DW, Li ZS. Prophylactic antibiotics cannot reduce infected pancreatic necrosis and mortality in acute necrotizing pancreatitis: evidence from a meta-analysis of randomized controlled trials. Am J Gastroenterol. 2008; 103(1): 104–110[Crossref]
  • [63] Xu T, Cai Q. Prophylactic antibiotic treatment in acute necrotizing pancreatitis: results from a metaanalysis. Scand J Gastroenterol. 2008; 43(10): 1249–1258[Crossref]
  • [64] Jafri NS, Mahid SS, Idstein SR, Hornung CA, Galandiuk S. Antibiotic prophylaxis is not protective in severe acute pancreatitis: a systematic review and meta-analysis. Am J Surg. 2009 Jun; 197(6): 806–813[Crossref]
  • [65] Jiang K, Huang W, Yang XN, Xia Q. Present and future of prophylactic antibiotics for severe acute pancreatitis. World J Gastroenterol. 2012 Jan; 2118(3): 279–284[Crossref]
  • [66] Wittau M, Mayer B, Scheele J, Henne-Bruns D, Dellinger EP, Isenmann R. Systematic review and meta-analysis of antibiotic prophylaxis in severe acute pancreatitis. Scandinavian Journal of Gastroenterology, 2011; 46: 261–270[Crossref]
  • [67] Ignatavicius P, Vitkauskiene A, Pundzius J, Dambrauskas Z, Barauskas G. Effects of prophylactic antibiotics in acute pancreatitis. HPB (Oxford). 2012 Jun; 14(6): 396–402
  • [68] Segarra-Newnham M, Hough A. Antibiotic prophylaxis in acute necrotizing pancreatitis revisited. Ann Pharmacother. 2009 Sep; 43(9): 1486–1495[Crossref]
  • [69] Beger HG, Gansauge F, Poch B, Schwarz M. The use of antibiotics for acute pancreatitis: is there a role? Curr Infect Dis Rep. 2009 Mar; 11(2): 101–107[Crossref]
Typ dokumentu
Identyfikator YADDA
JavaScript jest wyłączony w Twojej przeglądarce internetowej. Włącz go, a następnie odśwież stronę, aby móc w pełni z niej korzystać.